Aurinia Pharmaceuticals Inc
看多

Head and Shoulders projects $9.5-10.50 consolidation zone

84
快照

41% retracement from head to neckline, so 41% from neckline puts it at $10.50. There are multiple horizontal support zones, see chart that also correspond to this zone $9.50 - 10.50. Greenleaf (CEO) is a complete clown. Issuing a statement last week that guidance will likely be aggressive then he issued guidance that was approximately 30% below the analysts. He is a drag on this stock however at 1.5B market cap and projected annual sales of approximately 1B, this appears to be a good entry point now or waiting until the 9.50-10.50 zone.

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。